Cargando…
The Development of a COPD Exacerbation Recognition Tool (CERT) to Help Patients Recognize When to Seek Medical Advice
INTRODUCTION: Many patients with chronic obstructive pulmonary disease (COPD) do not report exacerbations and may benefit from simple guidance about when to seek medical attention, so we developed a COPD Exacerbation Recognition Tool (CERT). METHODS: The study was run across three sites in China in...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789323/ https://www.ncbi.nlm.nih.gov/pubmed/35087270 http://dx.doi.org/10.2147/COPD.S337644 |
_version_ | 1784639741805723648 |
---|---|
author | Jones, Paul W Wang, Chanzheng Chen, Ping Chen, Liping Wang, Daoxin Xia, Junbo Yang, Yang Wang, Yingyu Ma, Qianli |
author_facet | Jones, Paul W Wang, Chanzheng Chen, Ping Chen, Liping Wang, Daoxin Xia, Junbo Yang, Yang Wang, Yingyu Ma, Qianli |
author_sort | Jones, Paul W |
collection | PubMed |
description | INTRODUCTION: Many patients with chronic obstructive pulmonary disease (COPD) do not report exacerbations and may benefit from simple guidance about when to seek medical attention, so we developed a COPD Exacerbation Recognition Tool (CERT). METHODS: The study was run across three sites in China in patients who had an exacerbation within the previous year. Step 1: focus group qualitative study (total 48 patients) captured symptoms associated with an exacerbation. Step 2: cognitive debriefing to ensure items were appropriately worded. Step 3: 150 patients (69 years, 21% female, FEV(1) 63% predicted, CAT 15, 2 exacerbations in previous year) completed a questionnaire composed of the items from Steps 1 and 2 using two response options – severity during an exacerbation and magnitude of change from usual state. Responses were analysed in terms of frequency and tested for influence of demographic factors. Exploratory factor analysis (EFA) identified key domains. Using these results, an expert panel guided choice of items that formed the CERT. RESULTS: Following Steps 1 and 2, 29 candidate items were selected for Step 3. Response rates with the two response options were very similar. There was minimal influence of demographic factors on response to the items. EFA using the 11 items with the highest response rates identified two principal factors, Factor 1: breathlessness and activity limitation (79.1% of variance), Factor 2: cough and sputum (20.9% of variance). Five items were selected for the CERT based on response rate and EFA factor loading: worsening cough, increased sputum volume, shortness of breath, laborious breathing, and limitation of motion. Sensitivity analysis suggested that worsening of two or more symptoms had good sensitivity and specificity for the presence of an exacerbation. DISCUSSION: The CERT is an evidence-based tool to provide patients with simple-to-follow guidance about when to seek medical attention when their COPD symptoms worsen. |
format | Online Article Text |
id | pubmed-8789323 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-87893232022-01-26 The Development of a COPD Exacerbation Recognition Tool (CERT) to Help Patients Recognize When to Seek Medical Advice Jones, Paul W Wang, Chanzheng Chen, Ping Chen, Liping Wang, Daoxin Xia, Junbo Yang, Yang Wang, Yingyu Ma, Qianli Int J Chron Obstruct Pulmon Dis Original Research INTRODUCTION: Many patients with chronic obstructive pulmonary disease (COPD) do not report exacerbations and may benefit from simple guidance about when to seek medical attention, so we developed a COPD Exacerbation Recognition Tool (CERT). METHODS: The study was run across three sites in China in patients who had an exacerbation within the previous year. Step 1: focus group qualitative study (total 48 patients) captured symptoms associated with an exacerbation. Step 2: cognitive debriefing to ensure items were appropriately worded. Step 3: 150 patients (69 years, 21% female, FEV(1) 63% predicted, CAT 15, 2 exacerbations in previous year) completed a questionnaire composed of the items from Steps 1 and 2 using two response options – severity during an exacerbation and magnitude of change from usual state. Responses were analysed in terms of frequency and tested for influence of demographic factors. Exploratory factor analysis (EFA) identified key domains. Using these results, an expert panel guided choice of items that formed the CERT. RESULTS: Following Steps 1 and 2, 29 candidate items were selected for Step 3. Response rates with the two response options were very similar. There was minimal influence of demographic factors on response to the items. EFA using the 11 items with the highest response rates identified two principal factors, Factor 1: breathlessness and activity limitation (79.1% of variance), Factor 2: cough and sputum (20.9% of variance). Five items were selected for the CERT based on response rate and EFA factor loading: worsening cough, increased sputum volume, shortness of breath, laborious breathing, and limitation of motion. Sensitivity analysis suggested that worsening of two or more symptoms had good sensitivity and specificity for the presence of an exacerbation. DISCUSSION: The CERT is an evidence-based tool to provide patients with simple-to-follow guidance about when to seek medical attention when their COPD symptoms worsen. Dove 2022-01-21 /pmc/articles/PMC8789323/ /pubmed/35087270 http://dx.doi.org/10.2147/COPD.S337644 Text en © 2022 Jones et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Jones, Paul W Wang, Chanzheng Chen, Ping Chen, Liping Wang, Daoxin Xia, Junbo Yang, Yang Wang, Yingyu Ma, Qianli The Development of a COPD Exacerbation Recognition Tool (CERT) to Help Patients Recognize When to Seek Medical Advice |
title | The Development of a COPD Exacerbation Recognition Tool (CERT) to Help Patients Recognize When to Seek Medical Advice |
title_full | The Development of a COPD Exacerbation Recognition Tool (CERT) to Help Patients Recognize When to Seek Medical Advice |
title_fullStr | The Development of a COPD Exacerbation Recognition Tool (CERT) to Help Patients Recognize When to Seek Medical Advice |
title_full_unstemmed | The Development of a COPD Exacerbation Recognition Tool (CERT) to Help Patients Recognize When to Seek Medical Advice |
title_short | The Development of a COPD Exacerbation Recognition Tool (CERT) to Help Patients Recognize When to Seek Medical Advice |
title_sort | development of a copd exacerbation recognition tool (cert) to help patients recognize when to seek medical advice |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789323/ https://www.ncbi.nlm.nih.gov/pubmed/35087270 http://dx.doi.org/10.2147/COPD.S337644 |
work_keys_str_mv | AT jonespaulw thedevelopmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice AT wangchanzheng thedevelopmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice AT chenping thedevelopmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice AT chenliping thedevelopmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice AT wangdaoxin thedevelopmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice AT xiajunbo thedevelopmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice AT yangyang thedevelopmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice AT wangyingyu thedevelopmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice AT maqianli thedevelopmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice AT jonespaulw developmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice AT wangchanzheng developmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice AT chenping developmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice AT chenliping developmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice AT wangdaoxin developmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice AT xiajunbo developmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice AT yangyang developmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice AT wangyingyu developmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice AT maqianli developmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice |